The identified hub genes—MYC, EGFR, CDKN2A, ERBB2, CDK1, E2F1, TOP2A, MDM2, TGFB1, and FOXM1—play significant roles in BC progression and are potential biomarkers for diagnosis, prognosis, and therapy. The gene discussed is ERBB2; the disease is breast cancer.